Literature DB >> 15259756

Effect of warfarin nonadherence on control of the International Normalized Ratio.

Amy D Waterman1, Paul E Milligan, Laura Bayer, Gerald A Banet, Susan K Gatchel, Brian F Gage.   

Abstract

OBJECTIVE: The frequency and causes of ab- errant International Normalized Ratios (INRs) in warfarin recipients and the percentage explainable by warfarin nonadherence were studied.
METHODS: The medical records of patients whose warfarin therapy was monitored by a telephone-based anticoagulation service in a Midwestern urban hospital between March 2000 and March 2001 were reviewed for causes of out-of-range INRs, the percentage of out-of-range INRs attributable to warfarin nonadherence, and demographic and clinical variables predictive of nonadherence.
RESULTS: Data from 347 patients were studied. The cohort yielded 4305 INRs, of which 1002 (23%) were out of range (lower than 1.8 or higher than 3.4). Thirty-six percent of the out-of-range INRs were due to warfarin or dietary nonadherence, 9% were due to medical systems problems (including drug interactions), 18% were due to a change in clinical status, and 38% were idiopathic. Age younger than 65 years, age greater than 80 years, and living closer to the laboratory were predictive of warfarin nonadherence.
CONCLUSION: Warfarin nonadherence was the most common cause of explainable aberrant INRs in patients taking warfarin. Age younger than 65 years, age greater than 80 years, and living close to the laboratory were predictive of warfarin nonadherence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15259756     DOI: 10.1093/ajhp/61.12.1258

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  22 in total

Review 1.  Factors Affecting Patients' Perception On, and Adherence To, Anticoagulant Therapy: Anticipating the Role of Direct Oral Anticoagulants.

Authors:  Ekta Y Pandya; Beata Bajorek
Journal:  Patient       Date:  2017-04       Impact factor: 3.883

Review 2.  Drug adherence in patients taking oral anticoagulation therapy.

Authors:  Sebastian Ewen; Volker Rettig-Ewen; Felix Mahfoud; Michael Böhm; Ulrich Laufs
Journal:  Clin Res Cardiol       Date:  2013-09-03       Impact factor: 5.460

3.  Cost effectiveness of rivaroxaban for stroke prevention in German patients with atrial fibrillation.

Authors:  Alexander Mensch; Stephanie Stock; Björn Stollenwerk; Dirk Müller
Journal:  Pharmacoeconomics       Date:  2015-03       Impact factor: 4.981

4.  Predictors of unstable anticoagulation in African Americans.

Authors:  Larisa H Cavallari; Jonathan L Aston; Kathryn M Momary; Nancy L Shapiro; Shitalben R Patel; Edith A Nutescu
Journal:  J Thromb Thrombolysis       Date:  2008-06-19       Impact factor: 2.300

5.  Can we predict daily adherence to warfarin?: Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study.

Authors:  Alec B Platt; A Russell Localio; Colleen M Brensinger; Dean G Cruess; Jason D Christie; Robert Gross; Catherine S Parker; Maureen Price; Joshua P Metlay; Abigail Cohen; Craig W Newcomb; Brian L Strom; Mitchell S Laskin; Stephen E Kimmel
Journal:  Chest       Date:  2009-11-10       Impact factor: 9.410

6.  Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.

Authors:  Patrick P Kneeland; Margaret C Fang
Journal:  Patient Prefer Adherence       Date:  2010-03-24       Impact factor: 2.711

7.  Predictors of warfarin non-adherence in younger adults after valve replacement surgery in the South Pacific.

Authors:  Linda J Thomson Mangnall; David W Sibbritt; Nihaya Al-Sheyab; Robyn D Gallagher
Journal:  Heart Asia       Date:  2016-06-14

8.  Risk factors for nonadherence to warfarin: results from the IN-RANGE study.

Authors:  Alec B Platt; A Russell Localio; Colleen M Brensinger; Dean G Cruess; Jason D Christie; Robert Gross; Catherine S Parker; Maureen Price; Joshua P Metlay; Abigail Cohen; Craig W Newcomb; Brian L Strom; Mitchell S Laskin; Stephen E Kimmel
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-09       Impact factor: 2.890

9.  Comparison of three medication adherence measures in patients taking warfarin.

Authors:  Ye Wang; Ming Chai Kong; Yu Ko
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

10.  Multinational development of a questionnaire assessing patient satisfaction with anticoagulant treatment: the 'Perception of Anticoagulant Treatment Questionnaire' (PACT-Q).

Authors:  Martin H Prins; Alexia Marrel; Paulo Carita; David Anderson; Marie-Germaine Bousser; Harry Crijns; Silla Consoli; Benoit Arnould
Journal:  Health Qual Life Outcomes       Date:  2009-02-06       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.